These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15996240)

  • 1. High pre-transplant soluble CD30 levels are predictive of the grade of rejection.
    Rajakariar R; Jivanji N; Varagunam M; Rafiq M; Gupta A; Sheaff M; Sinnott P; Yaqoob MM
    Am J Transplant; 2005 Aug; 5(8):1922-5. PubMed ID: 15996240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection.
    Nafar M; Farrokhi F; Vaezi M; Entezari AE; Pour-Reza-Gholi F; Firoozan A; Eniollahi B
    Int Urol Nephrol; 2009; 41(3):687-93. PubMed ID: 19142743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft.
    Slavcev A; Honsova E; Lodererova A; Pavlova Y; Sajdlova H; Vitko S; Skibova J; Striz I; Viklicky O
    Transpl Immunol; 2007 Jul; 18(1):22-7. PubMed ID: 17584598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
    Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure?
    de Holanda MI; Matuck T; de Carvalho DDBM; Domingues EMFL; Curvo R; Glasberg DS; Santos AMG; Borela ÁM; Pôrto LC
    Transplant Proc; 2018 Apr; 50(3):728-736. PubMed ID: 29661425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts.
    Karahan GE; Caliskan Y; Ozdilli K; Kekik C; Bakkaloglu H; Caliskan B; Turkmen A; Sever MS; Oguz FS
    Int J Artif Organs; 2017 Jan; 39(11):547-552. PubMed ID: 28058698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE; Wu KS; Poole K; Newstead CG; Clark B
    J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30.
    Süsal C; Pelzl S; Döhler B; Opelz G
    J Am Soc Nephrol; 2002 Jun; 13(6):1650-6. PubMed ID: 12039995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival.
    Langan LL; Park LP; Hughes TL; Irish A; Luxton G; Witt CS; Christiansen FT
    Am J Transplant; 2007 Apr; 7(4):847-56. PubMed ID: 17391128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
    Pavlova Y; Viklicky O; Slatinska J; Bürgelova M; Süsal C; Skibova J; Honsová E; Striz I; Kolesar L; Slavcev A
    Transpl Immunol; 2011 Jul; 25(1):72-6. PubMed ID: 21376809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
    Wang D; Wu W; Yang S; Wang Q; Tan J
    Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
    Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
    Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation.
    Valke LL; van Cranenbroek B; Hilbrands LB; Joosten I
    Transpl Immunol; 2015 Jan; 32(1):18-22. PubMed ID: 25446808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD30 as a predictor of kidney graft outcome.
    Pelzl S; Opelz G; Wiesel M; Schnülle P; Schönemann C; Döhler B; Süsal C
    Transplantation; 2002 Jan; 73(1):3-6. PubMed ID: 11792970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.